Public

Eight biopharmas tap markets for $3.24B in early holiday rally

Wed, 10 Dec 2025 12:00:00 -0500

Christmas came early for a number of biopharma companies this year as eight companies collectively raised $3.24 billion in public offerings. Both Structure Therapeutics Inc. and Terns Pharmaceuticals Inc. announced upsized offerings of $650 million each, and Kymera Therapeutics Inc. raised $602 million, placing all three in the top 10 follow-on offerings of the year.

Alto and Fractyl keep the IPO momentum going

Fri, 02 Feb 2024 12:00:00 -0500

The week closed out with two IPOs on their way in. Alto Neuroscience Inc. (NASDAQ:ANRO) and Fractyl Health Inc. (NASDAQ:GUTS) both debuted on Wall Street with offerings looking to raise combined $238.6 million.

Aggressive licensor, cancer-focused Adlai Nortye files for US IPO

Tue, 01 Aug 2023 12:00:00 -0400

Hangzhou and New Jersey-based cancer biotech Adlai Nortye Ltd. – formerly Hangzhou Nuotai Pharmaceutical Co. Ltd. – announced plans to list on Nasdaq with its U.S. IPO filed on July 27.

Aggressive licensor, cancer-focused Adlai Nortye files for US IPO

Fri, 28 Jul 2023 12:00:00 -0400

Hangzhou and New Jersey-based cancer biotech Adlai Nortye Ltd. – formerly Hangzhou Nuotai Pharmaceutical Co. Ltd. – announced plans to list on Nasdaq with its U.S. IPO filed on July 27.

Precision dermatology firm Azitra announces $7.5M IPO

Fri, 16 Jun 2023 13:00:00 -0400

Azitra Inc. made its debut on the public market June 16, in the hopes of raising a relatively modest $7.5 million to enable it to fund clinical trials, manufacturing and R&D, as well as working capital and other general corporate purposes.

Health Guard Biotech nets $43M in Beijing IPO, shares plunge 15.43%

Tue, 21 Mar 2023 12:00:00 -0400

Health Guard Biotechnology Inc. raised ¥294 million (US$43 million) in an IPO on the SME-focused Beijing Stock Exchange, with the funds going to push the development of its HPV vaccines.

Health Guard Biotech nets $43M in Beijing IPO, shares plunge 15.43%

Thu, 16 Mar 2023 12:00:00 -0400

Health Guard Biotechnology Inc. raised ¥294 million (US$43 million) in an IPO on the SME-focused Beijing Stock Exchange, with the funds going to push the development of its HPV vaccines.

Cryofocus nets $27M in Hong Kong IPO for interventional cryotherapy devices

Tue, 03 Jan 2023 13:00:00 -0500

Cryofocus Medtech (Shanghai) Co. Ltd. has raised HK$210 million (US$27 million) on the Hong Kong Stock Exchange. Its shares opened at HK$18.5 apiece, fell over 6% and closed at HK$17.66 on the first trading day of Dec. 30, 2022. Its shares closed at HK$16.8 per share on Jan. 3, 2023.

Boan Biotech nets almost $19.6M in Hong Kong IPO

Tue, 03 Jan 2023 12:00:00 -0500

Boan Biotechnology Co. Ltd. raised HK$152.8 million (US$19.6 million) from a Hong Kong IPO, capital the company will use to speed up product development, expand marketing and ramp up manufacturing.

Boan Biotech nets almost $19.6M in Hong Kong IPO

Fri, 30 Dec 2022 12:00:00 -0500

Boan Biotechnology Co. Ltd. raised HK$152.8 million (US$19.6 million) from a Hong Kong IPO, capital the company will use to speed up product development, expand marketing and ramp up manufacturing.

3D Medicines nets $53M in Hong Kong IPO, shares rise over 20% on debut

Tue, 20 Dec 2022 12:00:00 -0500

3D Medicines Inc. has raised HK$408 million (US$52.5 million) in a listing on the Hong Kong Stock Exchange. Its shares opened at HK$29 apiece, jumped by more than 20% by the middle of the day, and closed at HK$31.45 on the first trading day of Dec. 15.

Gaush Meditech nets $86M in Hong Kong IPO, shares plunge 6.81% on debut

Mon, 19 Dec 2022 00:00:00 -0500

Gaush Meditech Ltd. raised HK$672 million (US$86.4 million) on a Hong Kong Stock Exchange listing. The company plans to use 38.2% of the funds to improve its research and development capability and speed up the commercialization of its patents in two years.

3D Medicines nets $53M in Hong Kong IPO, shares rise over 20% on debut

Thu, 15 Dec 2022 12:00:00 -0500

QT Imaging charts IPO via $151M SPAC deal

Wed, 14 Dec 2022 13:00:00 -0500

Transition ultrasound startup QT Imaging Inc. is poised to go public via a merger with Gigcapital5 Inc., a special purpose acquisition company (SPAC), in a deal that puts the equity value of the combination at $151 million. The combined company, QT Imaging Holdings Inc. will be traded on the NYSE under the ticker symbol QTI.

Scientech Medical raises $72M in Hong Kong listing

Tue, 08 Nov 2022 13:00:00 -0500

Lepu Scientech Medical Technology (Shanghai) Co. Ltd. raised HK$567 million (US$72.2 million) in a Hong Kong initial public offering. Its shares opened at HK$29.8 apiece, increased over 2% in the middle of the day and closed at HK$29.15 on Nov. 8.

BMC Medical nets $264M in Shenzhen IPO, shares surge over 140%

Tue, 01 Nov 2022 13:00:00 -0400

BMC Medical Co. Ltd. raised ¥1.918 billion (US$264 million) on the Shenzhen Stock Exchange. Its shares opened on Nov. 1 at ¥230 per share, surged more than 140% in the middle of the day and closed at ¥290.

Cowin Biotech nets $156M in Shanghai IPO

Tue, 25 Oct 2022 13:00:00 -0400

Jiangsu Cowin Biotech Co. Ltd. has raised ¥1.14 billion (US$156 million) in a listing on the Shanghai STAR Market. Its shares opened at ¥42.96 apiece, plunged over 13% by the middle of the day but closed at ¥43.62 on the first trading day on Oct. 25.

Jenscare raises $29M in HK IPO, shares jump over 9% on its debut

Wed, 12 Oct 2022 13:00:00 -0400

Jenscare Scientific Co. Ltd. has raised HK$225 million (US$29 million) in an initial public offering on the Stock Exchange of Hong Kong. Its shares opened at HK$28 per share, increased by over 9% in the middle of the day and closed at HK$28.25 on the first trading day of Oct. 10.

MGI raise $518M in Shanghai IPO, shares jump 14.71% on debut

Wed, 14 Sep 2022 13:00:00 -0400

MGI Tech Co. Ltd. raised ¥3.602 billion (US$518 million) on the Shanghai STAR Market. Shares (SHA: 688114) debuted at ¥87.18 apiece on the first trading day on Sept. 9. They closed at ¥124 per share on Sept. 14.

United Imaging raises $1.6B in Shanghai IPO, shares surge 75% in debut

Mon, 22 Aug 2022 13:00:00 -0400

Shanghai United Imaging Healthcare Co. Ltd. went public in the Shanghai Stock Exchange STAR Market and raised ¥11 billion (US$1.6 billion) in its initial public offering.

Nanjing Medlander raises $149M in STAR Market listing

Fri, 19 Aug 2022 00:00:00 -0400

Nanjing Medlander Medical Technology Co. Ltd. raised ¥1.01 billion (US$148.8 million) with its initial public offering on the Shanghai STAR Market.

Microport Neurotech debuts in Hong Kong, shares fall 0.162%

Mon, 18 Jul 2022 13:00:00 -0400

Microport Neurotech Ltd.’s shares started at HK$24.7 (US$3.15) per share, fell 0.162% and closed at HK$24.60 apiece on its first day of trading of July 15, 2022.

Mega Genomics raises $20M in Hong Kong IPO, shares jump 16.7%

Mon, 27 Jun 2022 13:00:00 -0400

Mega Genomics Ltd. raised HK$153.4 million (US$20 million) in an initial public offering on the Stock Exchange of Hong Kong. Its shares jumped 16.7% in the middle of the first trading day on June 22 and closed at HK$18 a share. Beijing-based Mega Genomics plans to allocate 30% of the proceeds to the sales, marketing, and commercialization of its consumer genetic testing and cancer screening services and products.

Alopexx architects PNAG vaccine, antibody, $17M IPO

Mon, 07 Mar 2022 13:00:00 -0500

Alopexx Inc. filed for an IPO that would bank as much as $17 million to continue the firm’s investigations of bacterial, fungal and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG).

Sirnaomics starts 2022 with $64M Hong Kong IPO

Tue, 04 Jan 2022 13:00:00 -0500

Sirnaomics Ltd. became the first RNA therapeutics company to list on the Hong Kong Stock Exchange (HKEX) with a $64 million initial public offering. Its shares (HKEX:2277) have since surged, rising to HK$93.90 ($12.04) on Jan. 4 following their debut at HK$65.90 per share.

Dice ‘raps’ IPO, Tyra banks big as Pasithea’s ideas bring up the rear

Wed, 15 Sep 2021 12:00:00 -0400

The market’s appetite for immunology candidates in chronic disease – in particular an oral interleukin-17 (IL-17) therapy for psoriasis – was proved by the upsized IPO pulled off by Dice Therapeutics Inc., and Tyra Biosciences Inc. benefited from the ongoing appetite in precision oncology in another, bigger-than-expected debut. Preclinical-stage Pasithea Therapeutics Inc. went public as well, albeit less spectacularly.

Hong Kong looks to introduce SPAC listings, but market unsure about impact

Tue, 10 Aug 2021 15:15:00 -0400

Hong Kong Exchanges and Clearing Ltd. (HKEX) has taken the first step towards allowing listings on the market via special purpose acquisition companies (SPACs), also known as “blank check” companies. The move has left biotech companies wondering if the change could provide the next big opportunity to join the market after pre-revenue companies were first allowed to list there under a 2018 main board listing rule paved the path for them to do so.

Hong Kong looks to introduce SPAC listings, but market unsure about impact

Fri, 06 Aug 2021 13:00:00 -0400

Vaccine firm Gdk Biotechnology debuts on Shanghai Star Market with $187M IPO

Tue, 03 Aug 2021 13:00:00 -0400

Jiangsu Gdk Biotechnology Co. Ltd. will further develop its vaccine pipeline after it started trading on the Shanghai Stock Exchange Star Market on Aug. 2, where it raised ¥1.21 billion ($187 million) through an initial public offering of 22 million shares. The company plans to use the proceeds from the listing to establish a manufacturing plant to produce its quadrivalent influenza vaccine and invest in R&D for other vaccine candidates, as well as replenish working capital and repay bank loans.

Brii Biosciences debuts in Hong Kong with $319M IPO, shares close 3.15% higher

Tue, 13 Jul 2021 13:00:00 -0400

Brii Biosciences Ltd. raised HK$2.482 billion (US$319 million) in its IPO in Hong Kong and will use the proceeds to support the development of its key assets, which includes programs for hepatitis B virus (HBV), HIV and drug-resistant infections.